During the past decade, Las Vegas Medical Research conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 15 clinical trials were completed, i.e. on average, 41.7% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 13 clinical trials were completed. i.e. 61.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Las Vegas Medical Research" #1 sponsor was "Eli Lilly and Company" with 12 trials, followed by "Biogen" with 6 trials sponsored, "Janssen Research & Development, LLC" with 4 trials sponsored, "Arena Pharmaceuticals" with 2 trials sponsored and "Galapagos NV" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Las Vegas Medical Research" #1 collaborator was "CoLucid Pharmaceuticals" with 2 trials as a collaborator, "Gilead Sciences" with 2 trials as a collaborator, "AbCellera Biologics Inc." with 1 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator and "Biogen" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Las Vegas Medical Research" are "Alzheimer's Disease" (9 trials), "Alzheimer Disease" (5 trials), "Ulcerative Colitis" (5 trials), "Crohn's Disease" (4 trials) and "COVID-19" (2 trials). Many other conditions were trialed in "Las Vegas Medical Research" in a lesser frequency.

Most popular intervention types in "Las Vegas Medical Research" are "Drug" (34 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (25 trials), "Aducanumab" (4 trials), "Donanemab" (4 trials), "Etrasimod" (3 trials) and "Filgotinib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Las Vegas Medical Research" are 36 trials for "All" genders.

Currently, there are NaN active trials in "Las Vegas Medical Research". undefined are not yet recruiting, 6 are recruiting, 9 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 11 completed trials in Las Vegas Medical Research, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Las Vegas Medical Research, 2 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".